Home The Word Brain My Amedeo FAQ Privacy About


Amedeo Chinese

For Medical Students & Physicians

A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever.

Download the free PDF: Amedeo Chinese PDF

  Nuclear Medicine

  Free Subscription


22.06.2026

1 Ann Nucl Med
1 BMC Neurol
6 Clin Nucl Med
1 J Cereb Blood Flow Metab
2 J Nucl Cardiol
7 J Nucl Med
1 Neurology
2 Nucl Med Commun
5 Phys Med Biol


   Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Ann Nucl Med

  1. NAOI J, Takanami K, Kiso K, Shidahara M, et al
    Detection ability of model observer for diagnosis of active cardiac sarcoidosis on (18)F-FDG-PET.
    Ann Nucl Med. 2026 Jun 15. doi: 10.1007/s12149-026-02248.
    PubMed         Abstract available


    BMC Neurol

  2. HONG R, Wu Z, Zhu S, Pan L, et al
    Efficacy and safety of (99m)Tc-MIBI SPECT-guided botulinum toxin injection in parkinsonian postural abnormality.
    BMC Neurol. 2026 Jun 17. doi: 10.1186/s12883-026-05072.
    PubMed         Abstract available


    Clin Nucl Med

  3. MOHAMED OAE, ElSayes KM, Morton K, Shaaban AM, et al
    Diffuse Splenic Uptake on 99mTc MDP Bone Scintigraphy Secondary to Transfusion-Related Hemosiderosis: Correlation With MRI Findings.
    Clin Nucl Med. 2026 Jun 18. doi: 10.1097/RLU.0000000000006580.
    PubMed         Abstract available

  4. BALOGLU MC, Sahin R, Tosunoglu Z, Ozturk AE, et al
    Clinical Value of 68Ga-DOTA-Bombesin PET/CT Compared With 18F-FDG PET/CT in the Staging of Breast Cancer.
    Clin Nucl Med. 2026 Jun 18. doi: 10.1097/RLU.0000000000006582.
    PubMed         Abstract available

  5. WENG Y, Yin H, Shi H
    Hepatic Inflammatory Pseudotumor Presenting as FDG-avid Liver Lesions in a Prostate Cancer Patient: A Diagnostic Pitfall on PET/CT.
    Clin Nucl Med. 2026 Jun 17. doi: 10.1097/RLU.0000000000006529.
    PubMed         Abstract available

  6. HWANG SH, Ahn WK, Cho H, Lee HW, et al
    Risk Stratification in Pediatric Non-Hodgkin Lymphoma Using Maximum Tumor Dissemination and Metabolic Tumor Burden on Baseline 18F-FDG PET/CT.
    Clin Nucl Med. 2026 Jun 17. doi: 10.1097/RLU.0000000000006556.
    PubMed         Abstract available

  7. IBRAHIM EA, Alper E
    Divergent PET Tracer Avidity in Synchronous Sarcomatoid Carcinoma With Osteosarcomatous Differentiation and Adenocarcinoma of the Prostate: Insights From Dual-Tracer 68Ga-PSMA and 18F-FDG PET/CT Imaging.
    Clin Nucl Med. 2026 Jun 17. doi: 10.1097/RLU.0000000000006576.
    PubMed         Abstract available

  8. BREGENZER CM, Trepp R, Dammann F, Kaderli RM, et al
    Parathyroid Carcinoma Mimicking a Parathyroid Adenoma on [18F]F-Choline-PET With Occult Metastases.
    Clin Nucl Med. 2026 Jun 17. doi: 10.1097/RLU.0000000000006555.
    PubMed         Abstract available


    J Cereb Blood Flow Metab

  9. RAMOS-JIMENEZ C, Nisha Aji K, Hung-Hsin Hsiao C, Grouza V, et al
    EXPRESS: Kinetic modeling of the Tropomyosin Receptor Kinases radioligand [(18)F]TRACK in human brain with high-resolution positron emission tomography.
    J Cereb Blood Flow Metab. 2026 Jun 19:271678X261463956.
    PubMed         Abstract available


    J Nucl Cardiol

  10. KATAHIRA M, Fukushima K, Ikeda A, Kasahara S, et al
    Right Ventricular Strain Analysis with PET-derived Feature Tracking: Direct Comparison with Magnetic Resonance using Hybrid PET/MR.
    J Nucl Cardiol. 2026 Jun 15:102793. doi: 10.1016/j.nuclcard.2026.102793.
    PubMed         Abstract available

  11. DORBALA S, Maurer MS, Cuddy SAM, Auer BD, et al
    Design and Rationale of the REVEAL PET Study: A Study of (124)I-evuzamitide to Diagnose Cardiac Amyloidosis.
    J Nucl Cardiol. 2026 Jun 15:102773. doi: 10.1016/j.nuclcard.2026.102773.
    PubMed         Abstract available


    J Nucl Med

  12. KUTEN J, Beattie BJ, Chahwan S, Schoder H, et al
    Functional Renal Assessment via Dynamic LAFOV (18)F-FDG PET/CT in a Patient with Recurrent Extranodal Marginal-Zone Lymphoma.
    J Nucl Med. 2026 Jun 18:jnumed.126.272086. doi: 10.2967/jnumed.126.272086.
    PubMed         Abstract available

  13. TIE X, Lee C, Perlman SB, Gowdy C, et al
    Evaluation of Baseline and Interim-Therapy PET Features for Prognostication in High-Risk Pediatric Hodgkin Lymphoma: A Retrospective Analysis of the AHOD1331 Trial.
    J Nucl Med. 2026 Jun 18:jnumed.125.270791. doi: 10.2967/jnumed.125.270791.
    PubMed         Abstract available

  14. KUMAR R, Ram A, Kumar S, Singh H, et al
    PCa Detection in PI-RADS 4 and 5 Lesions: Comparison of [(68)Ga]Ga-PSMA-11 PET/CT-Guided Robot-Assisted Biopsy Versus mpMRI Cognitive-Fusion TRUS-Guided Prostate Biopsy.
    J Nucl Med. 2026 Jun 18:jnumed.126.272036. doi: 10.2967/jnumed.126.272036.
    PubMed         Abstract available

  15. SHANBHAG A, Miller RJH, Kavanagh P, Ramirez G, et al
    Revisiting Perfusion in the Forgotten Right Ventricle: Artificial Intelligence-Enhanced Quantification on PET/CT.
    J Nucl Med. 2026 Jun 18:jnumed.125.271894. doi: 10.2967/jnumed.125.271894.
    PubMed         Abstract available

  16. BARBER AR, Edwards RS, Dos Santos SN, Emanuelli A, et al
    Imaging xCT with Immuno-PET in Therapy-Resistant Non-Small Cell Lung Cancer.
    J Nucl Med. 2026 Jun 18:jnumed.126.272920. doi: 10.2967/jnumed.126.272920.
    PubMed         Abstract available

  17. KREBS S, Salem AE, Nguyen NC, Sheth RA, et al
    Renal Medullary Carcinoma: Utility of [(18)F]FDG PET/CT in Evaluating Extent of Disease and Impact on Treatment Management.
    J Nucl Med. 2026 Jun 18:jnumed.126.272258. doi: 10.2967/jnumed.126.272258.
    PubMed         Abstract available

  18. CHOI H, Bae S, Na KJ
    End-to-End PET/CT Interpretation and Quantification with an LLM-Orchestrated AI Agent: A Real-World Pilot Study.
    J Nucl Med. 2026 Jun 18:jnumed.126.272362. doi: 10.2967/jnumed.126.272362.
    PubMed         Abstract available


    Neurology

  19. WANG ZY, Xin JW, Wang MY, Chen S, et al
    Clinical Evaluation of the Revised Biological and Clinical Staging Criteria for Alzheimer Disease in China.
    Neurology. 2026;107:e218184.
    PubMed         Abstract available


    Nucl Med Commun

  20. DREWS MA, Milosevic A, Zensen S, Opitz M, et al
    Diagnostic value of integrated 18F-fluorodeoxyglucose PET/MRI in initial staging and recurrence detection of Ewing sarcoma.
    Nucl Med Commun. 2026 Jun 12. doi: 10.1097/MNM.0000000000002196.
    PubMed         Abstract available

  21. ALQAHTANI MAM, Arita Y, Noordzij W, Kwee TC, et al
    Clinical assessment before PET/computed tomography: frequency and diagnostic impact.
    Nucl Med Commun. 2026 Jun 10. doi: 10.1097/MNM.0000000000002195.
    PubMed         Abstract available


    Phys Med Biol

  22. MEIKLE SR, Nuyts J, Jones T, Cherry SR, et al
    Landmark developments in nuclear medicine physics and engineering over the last 70 years.
    Phys Med Biol. 2026 Jun 18. doi: 10.1088/1361-6560.
    PubMed         Abstract available

  23. JIANG X, Zeng X, Yang H, Chen Z, et al
    A system-level DOI discrimination method based on SSDA for a brain-dedicated DOI-PET scanner.
    Phys Med Biol. 2026 Jun 17. doi: 10.1088/1361-6560.
    PubMed         Abstract available

  24. WETTENHOVI VV, Saarlemo NA, Djurabekova N, Kortelainen MJ, et al
    OMEGA V2: GPU-accelerated Python and MATLAB software for PET, SPECT, and CT reconstruction.
    Phys Med Biol. 2026 Jun 17. doi: 10.1088/1361-6560.
    PubMed         Abstract available

  25. HE X, Kratochwil N, Arino-Estrada G, Jain V, et al
    Experimental validation of Davis LUT module with photonic crystals for GATE simulations.
    Phys Med Biol. 2026;71:12NT01.
    PubMed         Abstract available

  26. ZHONG X, Pratx G
    A microscopic computational simulation of [(18)F]FDG transport and metabolism identifies valid regimes for compartmental analysis.
    Phys Med Biol. 2026;71.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Nuclear Medicine is free of charge.

Privacy / Datenschutzerklärung | Imprint / Impressum